---
schema_version: "secwatch.filing_event.v1"
accession: "0001819790-24-000006"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2024-01-18T23:59:59+00:00"
generated_at: "2026-06-06T22:03:25.568337+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Tarsus CMO Jose Trevejo departs; clinical dev reorganizes under COO

## Summary
- Dr. Trevejo steps down as CMO effective Jan 18, 2024; employment ends Feb 17, 2024.
- Clinical development and medical affairs reorganized under COO Dr. Sesha Neervannan.
- Transition approved Jan 11, 2024; company expresses gratitude for Dr. Trevejo's service.

## SEC filing metadata
- accession: 0001819790-24-000006
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2024-01-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000181979024000006/0001819790-24-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000181979024000006/tars-20240111.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001819790-24-000006
- JSON: https://secwatch.observer/filing/0001819790-24-000006.json
- Plain text: https://secwatch.observer/filing/0001819790-24-000006.txt

## Key facts
- Executive change
  Jose Trevejo departed as Chief Medical Officer at Tarsus Pharmaceuticals, Inc..
  - Action: departed
  - Role: Chief Medical Officer
  source text: On January 18, 2024, Tarsus Pharmaceuticals, Inc. (the “Company”) announced that Jose Trevejo, M.D., Ph.D. would be leaving his role as the Company’s Chief Medical Officer (the “Transition”), effective as of January 18, 2024 (the “Transition Date”), and leaving his employment with the Company on February 17, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819790/000181979024000006/0001819790-24-000006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.